Selected Grants
Non-Registry Agreement Clinical Trial
Clinical TrialPrincipal Investigator · Awarded by Chiesi USA, Inc · 2022 - 2025Leadiant Monitoring Agreement
ResearchPrincipal Investigator · Awarded by Leadiant Biosciences, Inc. · 2018 - 2023Leadiant Non-Patient Monitoring Agreement
ResearchPrincipal Investigator · Awarded by Leadiant Biosciences, Inc. · 2019 - 2022Orchard Agreement
ResearchPrincipal Investigator · Awarded by Orchard Therapeutics · 2019 - 2021Training Program in Inflammatory and Immunological Diseases
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1980 - 2017Non-Registry Agreement Clinical Trial
Clinical TrialPrincipal Investigator · Awarded by Chiesi USA, Inc · 2022 - 2025Leadiant Monitoring Agreement
ResearchPrincipal Investigator · Awarded by Leadiant Biosciences, Inc. · 2018 - 2023Leadiant Non-Patient Monitoring Agreement
ResearchPrincipal Investigator · Awarded by Leadiant Biosciences, Inc. · 2019 - 2022Orchard Agreement
ResearchPrincipal Investigator · Awarded by Orchard Therapeutics · 2019 - 2021Training Program in Inflammatory and Immunological Diseases
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1980 - 2017PEG-uricase as Therapy for Refractory Gout IND#11274
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2004 - 2009A Lymphoblast Model for Diseases of Purine Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1978 - 2007BIACORE 3000 Biosensor
EquipmentCo Investigator · Awarded by National Institutes of Health · 2002 - 2003Lymphoblast Model For Diseases Of Purine Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1978 - 2002A Lymphoblast Model For Diseases Of Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1992 - 1994A Lynphoblast Model For Diseases Of Purine Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1988 - 1991A Lymphoblast Model For Diseases Of Purine Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1984 - 1985External Relationships
- Chiesi USA (Chiesi Global Rare Diseases)
- Horizon Therapeutics (formerly Horizon Pharmaceuticals)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.